WNT4

WNT4 rs3820282 — The Estrogen-Responsive Molecular Switch in the Uterine Lining

Endometriosis — in which tissue resembling the uterine lining grows outside the uterus — affects
approximately 10% of women of reproductive age and is one of the leading causes of chronic pelvic
pain and infertility. The condition is strongly heritable, yet the molecular events that allow
retrograde endometrial cells to implant and survive on peritoneal surfaces remain incompletely
understood. rs3820282 stands out among endometriosis risk variants because functional experiments
have revealed its mechanism with unusual clarity: it
creates a new binding site for the estrogen receptor | ESR1: estrogen receptor alpha, a transcription
factor that mediates the downstream effects of estrogen on gene expression
directly within the first intron of WNT4, converting what was a transcriptionally quiet region into
an estrogen-responsive switch.

rs3820282 lies on chromosome 1p36.12 within intron 1 of the WNT4 gene, approximately 21 kb from
the widely-studied rs7521902. Although both SNPs tag the same 1p36 haplotype block and are in
linkage disequilibrium | LD: the tendency for nearby variants to be inherited together; variants
in high LD are often proxies for the same underlying causal signal
in European populations, rs3820282 has emerged from fine-mapping studies as the
more direct molecular actor — the variant whose alternative allele appears to alter
the DNA sequence itself rather than simply tagging a nearby causal change.

The Mechanism

WNT4 encodes a secreted glycoprotein belonging to the Wnt signaling family, which is essential
for the embryonic development of the female reproductive tract from Müllerian duct precursors
and for the monthly decidualization of the endometrium. The protein operates downstream of
the
IHH–COUPTFII pathway | the Indian Hedgehog – COUP transcription factor II axis, which coordinates
progesterone response in endometrial stromal cells during the secretory phase
to drive the transformation of endometrial stromal cells into specialized decidual cells —
a prerequisite for embryo implantation.

The T allele at rs3820282 changes the intronic sequence from C to T, introducing a
high-affinity recognition motif for estrogen receptor alpha (ERα). When estrogen levels
peak before ovulation, ERα bound to this newly created site activates WNT4 transcription
in the endometrial stroma, producing
1.48–3.27 log2-fold higher WNT4 expression | measured in CRISPR-edited knock-in mouse lines
carrying the human T allele; Pavličev et al. 2024 Nature Communications
during the proestrus and estrus cycle phases. The downstream effect is a uterine stromal
environment with enhanced invasibility — better at accepting an implanting embryo, but also
more permissive to attachment by ectopic endometrial fragments shed into the peritoneal cavity
during retrograde menstruation.

This same variant simultaneously acts as an
expression quantitative trait locus (eQTL) | a variant that affects how much RNA is produced from
a nearby gene rather than changing the protein sequence
for two nearby genes: LINC00339 (a long non-coding RNA, whose expression is decreased by the
risk allele) and CDC42 (a Rho GTPase involved in cytoskeletal organization and cell migration,
whose expression is increased). Elevated CDC42 activity may further facilitate the migratory
behavior of ectopic endometrial cells.

The Evidence

Fine-mapping of the chromosome 1p36 WNT4 region in
930 endometriosis cases and 959 controls | Luong et al. Int J Mol Epidemiol Genet,
2013 identified rs3820282 as one of three
variants with stronger association than the previously-reported rs7521902, noting its
position within recognition motifs for both ESR1 and ESR2 — a direct prediction of the
estrogen-receptor mechanism later confirmed experimentally.

In a 7,090-person fine-mapping study | Powell et al. Human Molecular Genetics,
2016 (2,594 endometriosis cases, 4,496 controls),
rs3820282 showed the strongest association at the 1p36.12 locus for endometriosis
(P = 1.84 × 10⁻⁵, OR = 1.244, 95% CI 1.126–1.375), outperforming rs7521902 as a direct
disease signal. The same variant was confirmed as an eQTL for both LINC00339 and CDC42
in endometrial tissue.

The functional confirmation arrived in 2024:
CRISPR knock-in experiments | Pavličev et al. Nature Communications,
2024 in mice introduced the human T allele
into the equivalent Wnt4 locus. Both independently generated knock-in lines showed
significantly higher uterine Wnt4 expression compared to wildtype animals during the
estrogen-peak phases (proestrus and estrus), confirming the estrogen-receptor-binding
mechanism proposed from human sequence analysis.

A striking feature of rs3820282 is antagonistic pleiotropy across reproductive tissues.
The same T allele that raises endometriosis and fibroid risk appears to confer reproductive
benefit: across multiple GWAS, the T allele is associated with longer gestation and reduced
preterm birth risk. Conversely, the C allele — which is relatively rare in East Asian
populations — is the risk allele for
pelvic organ prolapse | a condition in which the pelvic floor structures weaken and
pelvic organs descend into the vaginal canal
(OR 1.18, P = 3 × 10⁻²¹). This explains why the T allele has remained common despite
its association with endometriosis: in evolutionary terms, the same molecular mechanism
that facilitates embryo implantation comes at the cost of ectopic endometrial invasion.

Practical Implications

For women carrying one or two copies of the T allele, the most actionable implication is
awareness of endometriosis symptoms and a lower threshold for seeking specialist evaluation
rather than accepting menstrual pain as normal. The average diagnostic delay for
endometriosis is 4–11 years from first symptoms, driven by normalization of dysmenorrhea
and the requirement for laparoscopic confirmation.

The WNT4 locus is also associated with uterine fibroids (leiomyomas) at genome-wide
significance. T allele carriers may therefore warrant gynecological evaluation that includes
assessment for both conditions — a pelvic ultrasound can screen for both ovarian
endometriomas and uterine fibroid burden simultaneously.

No supplement or dietary intervention specifically targeting the estrogen-receptor-WNT4 axis
has been studied. Progestin-based hormonal therapies remain the mainstay of endometriosis
management and address the progesterone-resistance pathway through which WNT4 dysregulation
is thought to act.

Interactions

rs7521902 (WNT4 1p36.12 sentinel): rs7521902 is in moderate-to-high linkage disequilibrium
with rs3820282 in European populations, meaning both variants partly tag the same underlying
haplotype signal. In populations where LD is lower (East Asian, Brazilian cohorts), rs3820282
may be the more informative marker. Users carrying risk alleles at both loci reflect the same
biological signal rather than independent additive contributions.

rs4762326 (VEZT, chromosome 12q23.2): The VEZT locus encodes vezatin, a component of
adherens junctions that mediates cell-cell adhesion. VEZT and WNT4 represent two mechanistically
distinct pathways to ectopic endometrial implantation — cell adhesion capacity vs. estrogen-driven
stromal invasibility. Carrying risk alleles at both loci could compound endometriosis susceptibility
through complementary mechanisms, though formal gene-gene interaction data have not been published.

rs1250248 (FN1 — fibronectin 1): An epistatic interaction between the WNT4 locus (rs7521902)
and FN1 has been described for ovarian endometriosis (OR 1.56 for the interaction term;
Pagliardini et al. 2013, PMID 23142796). Fibronectin is a major extracellular matrix glycoprotein
that works alongside cell adhesion receptors; it may interact directly with the WNT4-driven
stromal invasibility that rs3820282 mediates.